Posts

Showing posts from November 19, 2026

CGM in Type 2 Diabetes Without Insulin: What the CONNECT Trial Shows | बिना इंसुलिन वाली डायबिटीज़ में CGM

World Diabetes Day (14 November) this year was about early action . A trial published last month in the New England Journal of Medicine fits that theme well. It asks a question we hear in clinic every week: "Doctor, I am not on insulin. Is a sensor (CGM) of any use to me?" The CONNECT trial in brief Who: 283 adults with type 2 diabetes, not on insulin , HbA1c 7.5% or higher, from 22 primary care practices in the USA. Mean age about 60 years; about 40% were on a GLP-1 receptor agonist and 37% on an SGLT2 inhibitor. What: randomised 1:1 to a real-time CGM (Dexcom G7) or routine care with a glucometer (fingerstick self-monitoring). Both groups got diet and exercise education and continued their usual medicines. How long: 26 weeks. Primary outcome: HbA1c. What they found Mean HbA1c fell from about 8.7% to 7.2% with CGM, versus 8.7% to 8.0% with routine care. The adjusted difference was -0.9 percentage points (95% CI -1.1 to -0.6). Time in range (70-180 mg/dL) w...